A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population

被引:5
|
作者
Hines, Laena [1 ]
Zhu, Denzel [2 ]
DeMasi, Matt [2 ]
Babar, Mustufa [2 ]
Chernyak, Victoria [2 ,3 ,4 ]
Kovac, Evan Z. [2 ,3 ]
Aboumohamed, Ahmed [2 ,3 ]
Sankin, Alex [2 ,3 ]
Agalliu, Ilir [2 ,3 ,5 ]
Watts, Kara L. [2 ,3 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
[2] Albert Einstein Coll Med, 1250 Waters Pl,Tower 1,Penthouse, Bronx, NY 10461 USA
[3] Montefiore Med Ctr, Dept Urol, 1250 Waters Pl,Tower 1,Penthouse, Bronx, NY 10461 USA
[4] Montefiore Med Ctr, Dept Radiol, Bronx, NY 10461 USA
[5] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA
关键词
prostate; magnetic resonance imaging; biopsy; logistic models; prostatic neoplasms; CANCER;
D O I
10.1097/JU.0000000000001810
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: NonHispanic Black (NHB) and Hispanic/Afro-Caribbean men have the highest risk of prostate cancer (PCa) compared to nonHispanic White (NHW) men. However, ethnicity-specific outcomes of targeted fusion biopsy (FB) for the detection of PCa are poorly characterized. We compared the outcomes of FB by Prostate Imaging Reporting and Data System (PI-RADS (R)) score and race/ ethnicity among a diverse population. Materials and Methods: We evaluated all men who underwent image-guided FB for suspicious lesions on prostate magnetic resonance imaging (>= PI-RADS 3) over a 2-year period. We examined associations of race/ethnicity and PI-RADS score with risk of PCa or clinically significant PCa (cs-PCa, Gleason Group >= 2) on FB using mixed-effects logistic regression models. Results: A total of 410 men with 658 lesions were analyzed, with 201 (49.0%) identified as NHB and 125 (30.5%) identified as Hispanic. NHB men had a twofold increase in the odds of detecting cs-PCa (OR=2.7, p=0.045), while Hispanic men had similar odds of detecting cs-PCa compared to NHW men. With regard to all PCa, NHB men had a similar increase in the odds of detecting all PCa (OR=2.4, p=0.050), which was borderline statistically significant compared to NHW men on FB. When we excluded men on active surveillance, NHB men had even stronger associations with detection of cs-PCa (OR=3.10, p=0.047) or all PCa (OR=2.77, p=0.032) compared to NHW men. Conclusions: NHB men have higher odds for overall PCa and cs-PCa on FB compared to NHW men. Further work may clarify differences per PI-RADS score. Clinicians should interpret prostate magnetic resonance imaging lesions with more caution in NHB men.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 42 条
  • [1] Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores
    Tomioka, Masayuki
    Seike, Kensaku
    Uno, Hiromi
    Asano, Nami
    Watanabe, Haruo
    Tomioka-Inagawa, Risa
    Kawase, Makoto
    Kato, Daiki
    Takai, Manabu
    Iinuma, Koji
    Tobisawa, Yuki
    Nakane, Keita
    Tsuchiya, Kunihiro
    Ito, Takayasu
    Koie, Takuya
    DIAGNOSTICS, 2023, 13 (15)
  • [2] Is transrectal ultrasound-guided systematic biopsy necessary after PI-RADS 4 is targeted?
    Kim, Hyun Soo
    Park, Byung Kwan
    PRECISION AND FUTURE MEDICINE, 2021, 5 (03): : 125 - 132
  • [3] Recent advances in image-guided targeted prostate biopsy
    Anna M. Brown
    Osama Elbuluk
    Francesca Mertan
    Sandeep Sankineni
    Daniel J. Margolis
    Bradford J. Wood
    Peter A. Pinto
    Peter L. Choyke
    Baris Turkbey
    Abdominal Imaging, 2015, 40 : 1788 - 1799
  • [4] Recent advances in image-guided targeted prostate biopsy
    Brown, Anna M.
    Elbuluk, Osama
    Mertan, Francesca
    Sankineni, Sandeep
    Margolis, Daniel J.
    Wood, Bradford J.
    Pinto, Peter A.
    Choyke, Peter L.
    Turkbey, Baris
    ABDOMINAL IMAGING, 2015, 40 (06): : 1788 - 1799
  • [5] Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy
    Meng, Xiaosong
    Chao, Brian
    Chen, Fei
    Huang, Richard
    Taneja, Samir S.
    Deng, Fang-Ming
    JOURNAL OF UROLOGY, 2021, 205 (03) : 748 - 754
  • [6] Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results
    Lai, Wei-Jen
    Wang, Hsin-Kai
    Liu, Hsian-Tzu
    Park, Byung Kwan
    Shen, Shu-Huei
    Lin, Tzu-Ping
    Chung, Hsiao-Jen
    Huang, Yi-Hsiu
    Chang, Yen-Hwa
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2016, 79 (11) : 618 - 624
  • [7] Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging
    Lee, Jong Hoon
    Lee, Chung Un
    Song, Wan
    Kang, Minyong
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Jeon, Hwang Gyun
    PROSTATE INTERNATIONAL, 2024, 12 (03) : 134 - 138
  • [8] Predictive value of PI-RADS classification in MRI-directed transrectal ultrasound guided prostate biopsy
    NiMhurchu, E.
    O'Kelly, F.
    Murphy, I. G.
    Lavelle, L. P.
    Collins, C. D.
    Lennon, G.
    Galvin, D.
    Mulvin, D.
    Quinlan, D.
    McMahon, C. J.
    CLINICAL RADIOLOGY, 2016, 71 (04) : 375 - 380
  • [9] Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement
    Arcot, Rohith
    Sekar, Sitharthan
    Kotamarti, Srinath
    Krischak, Madison
    Michael, Zoe D.
    Foo, Wen-Chi
    Huang, Jiaoti
    Polascik, Thomas J.
    Gupta, Rajan T.
    ABDOMINAL RADIOLOGY, 2022, 47 (08) : 2917 - 2927
  • [10] Outcomes of Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy of PI-RADS 3, 4, and 5 Lesions
    Gosein, Maria
    Pang, Emily
    Chang, Silvia
    Black, Peter
    Goldenberg, Larry
    Harris, Alison
    Yasenjiang, Jason
    Yousefi, Masoud
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2018, 69 (03): : 303 - 310